Prevalence and factors associated with oxford /AstraZeneca vaccine adverse effects : (Record no. 14412)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01108nam a22002417a 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OSt |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20220721085224.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 220721b ||||| |||| 00| 0 eng d |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | BUL |
Language of cataloging | eng |
Transcribing agency | BUL |
Modifying agency | BUL |
Description conventions | rda |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Edition number | 22 |
Classification number | 614.592 |
Item number | ONY |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Personal name | Onyango, Jagire |
245 ## - TITLE STATEMENT | |
Title | Prevalence and factors associated with oxford /AstraZeneca vaccine adverse effects : |
Remainder of title | a cross sectional study in Tororo, Eastern Uganda / |
Statement of responsibility, etc. | Onyango Jagire |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | [Mbale, Uganda ] : |
Name of publisher, distributor, etc. | Busitema University, |
Date of publication, distribution, etc. | 2022 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | xii, 41, [8] p. : |
Other physical details | ill. ; |
Dimensions | 30 cm |
500 ## - GENERAL NOTE | |
General note | Contents <br/>Chapter 1. Introduction<br/>Chapter 2. Literature Review<br/>Chapter 3. Materials and Methods <br/>Chapter 4. Results of the study<br/>Chapter 5. Discussions, Conclusions and Recommendations<br/>Chapter 6. Conclusion and Recommendation |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc. note | Includes References |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Viral Vaccines |
Form subdivision | Research |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | COVID-19 Disease |
Form subdivision | Vaccination |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | AstraZeneca |
Form subdivision | Firm |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Research |
Form subdivision | Reports |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Dewey Decimal Classification |
Koha item type | Book Closed Access |
Classification part | 614.592414 |
Item part | 1 |
Call number prefix | ONY |
Call number suffix | 614.592414 ONY |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Source of acquisition | Total Checkouts | Full call number | Barcode | Date last seen | Copy number | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dewey Decimal Classification | Health Sciences Library | Health Sciences Library | 07/21/2022 | Donation | 614.592 ONY 1 | MBAL22067007 | 07/21/2022 | 1 | 07/21/2022 | Book Closed Access |